The cerebrovascular response to hypocapnia in children receiving propofol

Cengiz Karsli1, Igor Luginbuehl, Bruno Bissonnette

  • 1From the Department of Anesthesia, The Hospital for Sick Children and the University of Toronto, Toronto, Ontario, Canada.

Anesthesia and Analgesia
|September 24, 2004
PubMed

Insights

Hyperventilation to end-tidal carbon dioxide (ETco(2)) below 30 mm Hg does not further reduce cerebral blood flow velocity in children under propofol anesthesia. This suggests lower ETco(2) targets may not be necessary for managing intracranial pressure.

Area of Science:

  • Pediatric Anesthesiology
  • Neurocritical Care
  • Cerebrovascular Physiology

Background:

  • Hypocapnia is a strategy to reduce intracranial pressure (ICP) during neurosurgery.
  • Cerebrovascular reactivity to carbon dioxide (CCO(2)R) is crucial for managing cerebral blood flow.
  • Previous studies suggested a plateau in CCO(2)R below 35 mm Hg end-tidal carbon dioxide (ETco(2)) in children.

Purpose of the Study:

  • To precisely define the relationship between ETco(2) and cerebral blood flow velocity (V(mca)) in children.
  • To investigate the plateau effect of CCO(2)R at lower ETco(2) levels during propofol anesthesia.
  • To determine the optimal ETco(2) threshold for achieving maximal reduction in V(mca) in pediatric patients.

Main Methods:

  • Utilized transcranial Doppler (TCD) sonography to measure V(mca) in 27 healthy children.
  • Adjusted ETco(2) in small increments (1-2 mm Hg) between 24 and 40 mm Hg.
  • Administered standardized propofol infusion and caudal epidural block for anesthesia.

Main Results:

  • An exponential relationship was observed between ETco(2) and V(mca) above 30 mm Hg (r = 0.82).
  • V(mca) showed no significant change with ETco(2) levels below 30 mm Hg (r = 0.06).
  • No significant alterations in heart rate or arterial blood pressure were noted.

Conclusions:

  • Hyperventilation to ETco(2) below 30 mm Hg may not provide additional benefits in reducing cerebral blood flow velocity in children receiving propofol.
  • Current recommendations for managing intracranial pressure via hyperventilation in this population may be reconsidered.
  • Findings suggest that targeting ETco(2) values above 30 mm Hg is sufficient for achieving maximal cerebrovascular effects under propofol anesthesia in children.

Related Concept Videos

Hyperpnea and Hyperventilation01:25

Hyperpnea and Hyperventilation

Hyperventilation refers to a higher-than-normal rate and depth of breathing, often associated with anxiety attacks. This excessive breathing surpasses the body's need to expel CO2, leading to a condition known as hypocapnia - an unusually low level of carbon dioxide in the blood. Hypocapnia can constrict cerebral blood vessels, reducing blood flow to the brain, which may result in dizziness or fainting. Early signs include tingling and muscle spasms in the hands and face, caused by falling...
Assessment of Diffusion and Perfusion01:17

Assessment of Diffusion and Perfusion

Understanding and evaluating diffusion and perfusion is critical in assessing a patient's respiratory and circulatory health. These processes play key roles in maintaining the body's internal environment, ensuring that tissues receive adequate oxygen while waste products are efficiently removed.
The Role of Diffusion in Respiration
Diffusion is the process by which molecules move from an area of higher concentration to an area of lower concentration. In the respiratory system, this principle...
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Chemical Factors Affecting Respiration Centers01:31

Chemical Factors Affecting Respiration Centers

Chemical factors such as changing CO2, O2, and H+ levels in arterial blood play a critical role in influencing respiration depth and rates. These variations are detected by chemoreceptors—specialized sensors located in two primary body areas. Central chemoreceptors are found throughout the brain stem, including the ventrolateral medulla, while peripheral chemoreceptors are located in the aortic arch and carotid arteries.
CO2 has a potent influence on respiration and is strictly regulated. Under...
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...